PharmaCCX is developing a technology platform to enable pharma and payers to speed up their pricing negotiations, getting drugs to patients in need more quickly. Their model allows parties to confidentially explore performance- and indication-based pricing, which better aligns value with market dynamics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/20/18 | $3,000,000 | Seed |
Accel Partners Atlantic Labs Green D Ventures | undisclosed |
